Thomas N. Kledal

1.5k total citations
15 papers, 1.2k citations indexed

About

Thomas N. Kledal is a scholar working on Epidemiology, Oncology and Molecular Biology. According to data from OpenAlex, Thomas N. Kledal has authored 15 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 6 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Thomas N. Kledal's work include Cytomegalovirus and herpesvirus research (7 papers), Viral-associated cancers and disorders (6 papers) and Herpesvirus Infections and Treatments (5 papers). Thomas N. Kledal is often cited by papers focused on Cytomegalovirus and herpesvirus research (7 papers), Viral-associated cancers and disorders (6 papers) and Herpesvirus Infections and Treatments (5 papers). Thomas N. Kledal collaborates with scholars based in Denmark, Canada and United Kingdom. Thomas N. Kledal's co-authors include Mette M. Rosenkilde, Thue W. Schwartz, Hans Bräuner‐Osborne, Hans Rudolf Lüttichau, Sami Alouani, Ian Clark‐Lewis, Edward S. Mocarski, Jesper Eugen‐Olsen, Timothy N. C. Wells and Jan Gerstoft and has published in prestigious journals such as Science, Journal of Biological Chemistry and Circulation.

In The Last Decade

Thomas N. Kledal

15 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas N. Kledal Denmark	12	600	445	441	265	112	15	1.2k
Seigo Terawaki Japan	13	485 0.8×	868 2.0×	565 1.3×	387 1.5×	138 1.2×	28	1.7k
Pilar Lucas Spain	18	352 0.6×	635 1.4×	220 0.5×	643 2.4×	73 0.7×	39	1.6k
Takao Kurihara United States	9	419 0.7×	631 1.4×	114 0.3×	530 2.0×	64 0.6×	9	1.3k
Mauro Biffi Italy	15	476 0.8×	1.1k 2.5×	171 0.4×	694 2.6×	225 2.0×	27	2.1k
Antonio Alcina Spain	23	206 0.3×	625 1.4×	243 0.6×	405 1.5×	61 0.5×	61	1.4k
Alla Pritsker United States	13	176 0.3×	334 0.8×	132 0.3×	460 1.7×	147 1.3×	18	1.3k
Lianxian Cui China	24	378 0.6×	1.2k 2.8×	186 0.4×	274 1.0×	61 0.5×	56	1.6k
Benjamin L. J. Webb United Kingdom	17	152 0.3×	324 0.7×	267 0.6×	606 2.3×	97 0.9×	19	1.2k
Simon Yu United States	11	233 0.4×	587 1.3×	150 0.3×	474 1.8×	72 0.6×	12	1.1k
Paulette L. Wright United States	14	192 0.3×	369 0.8×	99 0.2×	497 1.9×	56 0.5×	18	1.0k

Countries citing papers authored by Thomas N. Kledal

Since Specialization

Citations

This map shows the geographic impact of Thomas N. Kledal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas N. Kledal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas N. Kledal more than expected).

Fields of papers citing papers by Thomas N. Kledal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas N. Kledal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas N. Kledal. The network helps show where Thomas N. Kledal may publish in the future.

Co-authorship network of co-authors of Thomas N. Kledal

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas N. Kledal. A scholar is included among the top collaborators of Thomas N. Kledal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas N. Kledal. Thomas N. Kledal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Weis, Nina, et al.. (2023). Amantadine for COVID-19 treatment (ACT) study: a randomized, double-blinded, placebo-controlled clinical trial. Clinical Microbiology and Infection. 29(10). 1313–1319. 10 indexed citations

Kledal, Thomas N., et al.. (2021). Molecular Properties and Therapeutic Targeting of the EBV-Encoded Receptor BILF1. Cancers. 13(16). 4079–4079. 9 indexed citations

Ribeiro, Rafaela Vanin Pinto, Terrance Ku, Aizhou Wang, et al.. (2021). Ex vivo treatment of cytomegalovirus in human donor lungs using a novel chemokine-based immunotoxin. The Journal of Heart and Lung Transplantation. 41(3). 287–297. 22 indexed citations

Toft‐Bertelsen, Trine L., Mads Gravers Jeppesen, Karin Giller, et al.. (2021). Amantadine inhibits known and novel ion channels encoded by SARS-CoV-2 in vitro. Communications Biology. 4(1). 1347–1347. 50 indexed citations

Ku, Terrance, Victor H. Ferreira, M. Galasso, et al.. (2020). Targeting Latent Human Cytomegalovirus (CMV) with a Novel Fusion Toxin Protein during Ex Vivo Lung Perfusion. The Journal of Heart and Lung Transplantation. 39(4). S83–S83. 3 indexed citations

Lyngaa, Rikke, et al.. (2010). Cell transformation mediated by the Epstein–Barr virus G protein-coupled receptor BILF1 is dependent on constitutive signaling. Oncogene. 29(31). 4388–4398. 40 indexed citations

Rosenkilde, Mette M., Tau Benned‐Jensen, Helene Søgaard Andersen, et al.. (2006). Molecular Pharmacological Phenotyping of EBI2. Journal of Biological Chemistry. 281(19). 13199–13208. 91 indexed citations

Rosenkilde, Mette M., Thomas N. Kledal, & Thue W. Schwartz. (2005). High Constitutive Activity of a Virus-Encoded Seven Transmembrane Receptor in the Absence of the Conserved DRY Motif (Asp-Arg-Tyr) in Transmembrane Helix 3. Molecular Pharmacology. 68(1). 11–19. 56 indexed citations

Brocchieri, Luciano, Thomas N. Kledal, Samuel Karlin, & Edward S. Mocarski. (2005). Predicting Coding Potential from Genome Sequence: Application to Betaherpesviruses Infecting Rats and Mice. Journal of Virology. 79(12). 7570–7596. 52 indexed citations

10.

Weis, Michael, Thomas N. Kledal, Ken Y. Lin, et al.. (2004). Cytomegalovirus Infection Impairs the Nitric Oxide Synthase Pathway. Circulation. 109(4). 500–505. 125 indexed citations

11.

Paulsen, Sarah Juel, Mette M. Rosenkilde, Jesper Eugen‐Olsen, & Thomas N. Kledal. (2004). Epstein-Barr Virus-Encoded BILF1 Is a Constitutively Active G Protein-Coupled Receptor. Journal of Virology. 79(1). 536–546. 104 indexed citations

12.

Knudsen, Troels Bygum, Thomas N. Kledal, Ove Andersen, Jesper Eugen‐Olsen, & Thomas Birk Kristiansen. (2003). Severe Acute Respiratory Syndrome – a New Coronavirus from the Chinese Dragon's Lair*. Scandinavian Journal of Immunology. 58(3). 277–284. 13 indexed citations

13.

Rosenkilde, Mette M., Thomas N. Kledal, Peter Johannes Holst, & Thue W. Schwartz. (2000). Selective Elimination of High Constitutive Activity or Chemokine Binding in the Human Herpesvirus 8 Encoded Seven Transmembrane Oncogene ORF74. Journal of Biological Chemistry. 275(34). 26309–26315. 51 indexed citations

14.

Rosenkilde, Mette M., Thomas N. Kledal, Hans Bräuner‐Osborne, & Thue W. Schwartz. (1999). Agonists and Inverse Agonists for the Herpesvirus 8-encoded Constitutively Active Seven-transmembrane Oncogene Product, ORF-74. Journal of Biological Chemistry. 274(2). 956–961. 161 indexed citations

15.

Kledal, Thomas N., Mette M. Rosenkilde, Graham Simmons, et al.. (1997). A Broad-Spectrum Chemokine Antagonist Encoded by Kaposi's Sarcoma-Associated Herpesvirus. Science. 277(5332). 1656–1659. 376 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact